November 13-14, 2019 - Het Pand, University of Ghent, Belgium

2nd Conference on Next Generation Sequencing
for Adventitious Virus Detection in
Human and Veterinary Biologics

An IABS-EU Meeting

Register Here!

Registration and information about the meeting here

Meeting objectives
T
his meeting will focus on the current scientific data and knowledge related to the use of next generation sequencing technologies for adventitious virus detection in biological products. Discussions will include ongoing efforts and future needs toward standardization and validation of the technical and bioinformatics steps involved in NGS for its applications in characterization and safety evaluation of biologics, including human and animal vaccines. The meeting will bring together representatives from industry, academia, technology providers, and international regulatory bodies for developing a scientific consensus regarding readiness of NGS for detection of adventitious viruses in biologics.

ABSTRACT SUBMISSIONS

Abstracts will be considered for talks/posters.
Approx: 500 words
Submission deadline: May 31, 2019.

Please send submission to This email address is being protected from spambots. You need JavaScript enabled to view it.
Subject: Abstract for 2nd IABS NGS meeting


The following topics related to NGS for human and veterinary biologics will be considered:
Sample preparation and processing
Standards and Standardization
Bioinformatics strategies and pipelines
Follow up of signals
Applications for adventitious virus testing in biologics
Virus discovery
Regulatory challenges

Scientific Committee

Dieter Deforce, Ghent University / Federal Agency for Medicines and Health Products of Belgium (FAMHP)
Sebastiaan Theuns, Ghent University / PROVAXS 
Arifa Khan, U.S. Food and Drug Administration (FDA)
Pieter Neels, International Alliance for Biological Standardization (IABS)
Sven Arnouts, Ghent University / PROVAXS
Johannes Blümel, Paul-Ehrlich Institut (PEI)
William Egan, GlaxoSmithKline Vaccines
Carmen Jungbäck, International Alliance for Biological Standardization (IABS)
Ivana Knezevic, World Heath Organization (WHO)
Laurent Mallet, Sanofi Pasteur
Gerald Schumann, Paul-Ehrlich Institut (PEI)
Joseph Victoria, Boehringer-Ingelheim

Register Here

 

 

 

Use the buttons below if you would like to share this info :

International Alliance for Biological Standardization


Twitter Feed

Register for IABS #RabiesElimination conference. Bangkok. December 3-4, 2019 Topic: Global Strategic Plan for the… https://t.co/4Ead5Fd0dS
IABS #diagnosticsveterinary workshop. Topic: Survival of viral pathogens in animal feed ingredients under transboun… https://t.co/Mpx7gHZZ6V
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.